A Single-arm, Single-center Clinical Study of Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.
Latest Information Update: 01 Oct 2024
At a glance
- Drugs Fruquintinib (Primary) ; Adebrelimab
- Indications Colorectal cancer
- Focus Therapeutic Use
- 01 Oct 2024 New trial record